Three Methods Evaluated for Malaria Detection
|
By LabMedica International staff writers Posted on 23 May 2017 |

Image: Malaria parasites in a red blood cell (Photo courtesy of SPL).
Malaria is a debilitating disease with high morbidity and mortality in Africa, commonly caused by different species of the genus Plasmodium in humans. Misdiagnosis is a major challenge in endemic areas because of other disease complications and technical expertise of the medical laboratory staff.
The microscopic examination of Giemsa-stained thick and thin blood films has been used for the laboratory diagnosis of malaria for many years. The limitation of microscopy led to the development of reliable, easy-to-perform rapid diagnostic tests (RDTs) to detect the presence of malaria parasites at levels of accuracy compared to skilled microscopists.
Scientists at the Federal University Ndufu-Alike Ikwo and their colleagues used simple random sampling of a populations comprised of individuals who had shown clinical signs of malaria and in whom test for malaria parasite have been requested for by clinicians. The subject population included persons of different age groups such as children, adults and pregnant women. Peripheral blood samples were collected by finger prick and by venipuncture.
The study participants were screened for malaria parasites using Giemsa-stained malaria microscopy, three RDT kits, among the specimens collected, a total of 50 were randomly selected for nested polymerase chain reaction (PCR). Three different commercially available RDT kits for malaria parasites having different sensitivity and specificity were used to detect malaria parasites in the blood samples. These were; Carestart, SD Bioline PF and SD Bioline PF/PV. Molecular analysis was performed using a PCR technique based on amplification of 18s rRNA genes.
The team reported that malaria parasite was detected in 109/420 (25.95%) of the subjects by microscopy and all the species detected by microscopy were observed to be P. falciparum. Among the subjects studied, 96 (22.9%), 64 (15.2%) and 230 (54.8%) were positive by Carestart, SD Bioline PF and SD Bioline PF/PV respectively. Among the specimens that were subjected to molecular analysis, 16 (32.0%) were positive while 34 (68.0%) were negative for Plasmodium genes. Plasmodium falciparum was observed in all positive cases, P. malariae was present in 5/16 cases while P. ovale was present in 1/16 subject. Both of the latter species were present as co-infection with P. falciparum in all the subjects they were found.
The authors concluded that microscopy is still a good method for the diagnosis of malaria and having a good measure of agreement with PCR. Hence it is recommended that the laboratory diagnosis of malaria be performed using both microscopy and RDT of high sensitivity and specificity. The combination of these methods will ensure that laboratory reports on malaria diagnosis are of very high accuracy. The study was published on May 6, 2017, in the Malaria Journal.
The microscopic examination of Giemsa-stained thick and thin blood films has been used for the laboratory diagnosis of malaria for many years. The limitation of microscopy led to the development of reliable, easy-to-perform rapid diagnostic tests (RDTs) to detect the presence of malaria parasites at levels of accuracy compared to skilled microscopists.
Scientists at the Federal University Ndufu-Alike Ikwo and their colleagues used simple random sampling of a populations comprised of individuals who had shown clinical signs of malaria and in whom test for malaria parasite have been requested for by clinicians. The subject population included persons of different age groups such as children, adults and pregnant women. Peripheral blood samples were collected by finger prick and by venipuncture.
The study participants were screened for malaria parasites using Giemsa-stained malaria microscopy, three RDT kits, among the specimens collected, a total of 50 were randomly selected for nested polymerase chain reaction (PCR). Three different commercially available RDT kits for malaria parasites having different sensitivity and specificity were used to detect malaria parasites in the blood samples. These were; Carestart, SD Bioline PF and SD Bioline PF/PV. Molecular analysis was performed using a PCR technique based on amplification of 18s rRNA genes.
The team reported that malaria parasite was detected in 109/420 (25.95%) of the subjects by microscopy and all the species detected by microscopy were observed to be P. falciparum. Among the subjects studied, 96 (22.9%), 64 (15.2%) and 230 (54.8%) were positive by Carestart, SD Bioline PF and SD Bioline PF/PV respectively. Among the specimens that were subjected to molecular analysis, 16 (32.0%) were positive while 34 (68.0%) were negative for Plasmodium genes. Plasmodium falciparum was observed in all positive cases, P. malariae was present in 5/16 cases while P. ovale was present in 1/16 subject. Both of the latter species were present as co-infection with P. falciparum in all the subjects they were found.
The authors concluded that microscopy is still a good method for the diagnosis of malaria and having a good measure of agreement with PCR. Hence it is recommended that the laboratory diagnosis of malaria be performed using both microscopy and RDT of high sensitivity and specificity. The combination of these methods will ensure that laboratory reports on malaria diagnosis are of very high accuracy. The study was published on May 6, 2017, in the Malaria Journal.
Latest Microbiology News
- Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
- Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
- Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
- Viral Load Tests Can Help Predict Mpox Severity
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Blood Test Accurately Detects Brain Amyloid Pathology in Symptomatic Patients
New research has reinforced the use of a novel blood test as a highly accurate tool for detecting brain amyloid pathology in symptomatic patients, helping healthcare professionals in diagnosing Alzheimer’s disease.... Read more
New Molecular Test Improves Diagnostic Accuracy of Lyme Disease
Diagnosing Lyme disease early remains one of the biggest challenges in infectious disease care. The condition is increasing across the United States, especially in the Northeast, although many patients... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read morePathology
view channel
AI Tool Predicts Treatment Success in Rectal Cancer Patients
Artificial intelligence (AI) may soon help clinicians identify which rectal cancer patients are likely to respond well to treatment, using only the routine biopsy slides already obtained at diagnosis.... Read more
Blood Test and Sputum Analysis Predict Acute COPD Exacerbation
Chronic obstructive pulmonary disease (COPD) remains a major contributor to global illness, largely driven by cigarette smoking and marked by irreversible lung damage. Acute exacerbations can accelerate... Read more
AI Tool to Transform Skin Cancer Detection with Near-Perfect Accuracy
Melanoma continues to be one of the most difficult skin cancers to diagnose because it often resembles harmless moles or benign lesions. Traditional AI tools depend heavily on dermoscopic images alone,... Read more
Unique Immune Signatures Distinguish Rare Autoimmune Condition from Multiple Sclerosis
Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) is a rare autoimmune disorder in which the immune system attacks the myelin sheath in the central nervous system. Although symptoms... Read moreTechnology
view channel
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
Detecting lung cancer early remains one of the biggest challenges in oncology, largely because current tools are invasive, expensive, or unable to identify the disease in its earliest phases.... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








